Platelet activation during haemodialysis: Comparison of cuprammonium rayon and polysulfone membranes

Abel Thijs, Muriel P.C. Grooteman, Sonja Zweegman, Menso J. Nubé, Peter C. Huijgens, Coen D.A. Stehouwer

Research output: Contribution to journalArticleAcademicpeer-review

13 Citations (Scopus)


Background/Aim: Haemodialysis-treated patients are at a high risk of developing cardiovascular disease. Part of this risk may be attributable to the type of the dialysis membrane used. We evaluated whether different dialysis membranes differ with respect to platelet activation. Methods: In a randomized crossover trial, the platelet activation was measured in 14 patients treated with two different dialyzers (cuprammonium rayon membrane and polysulfone membrane). We compared the platelet activation over the dialyzer and between dialyzers after several weeks of dialysis. Results: There were no differences between the two dialyzers in platelet activation over the dialyzer. After 2 weeks, however, the expression of CD62P, CD63, and PAC-1 was statistically significantly lower after cuprammonium membrane treatment than after polysulfone membrane treatment (mean fluorescence intensity in arbitrary units 8.0 vs. 11.1, 2.64 vs. 4.01, and 5.61 vs. 9.74, respectively). Conclusion: Dialysis with a polysulfone membrane seems to lead to more platelet activation than dialysis with a cuprammonium membrane.

Original languageEnglish
Pages (from-to)389-394
Number of pages6
JournalBlood Purification
Issue number5-6
Publication statusPublished - 1 Jan 2008


  • Biocompatibility, dialysis membranes
  • Cuprammonium rayon vs. polysulfone membranes
  • Platelet activation, haemodialysis

Cite this